NHS National Generic Pharmaceuticals - Lenalidomide

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Framework (Products)
Duration
1 year
Value
£26M
Sector
HEALTH
Published
30 Sep 2022
Delivery
01 Sep 2022 to 31 Aug 2023
Deadline
18 Jul 2022 13:00

Concepts

Location

Geochart for 1 buyers and 14 suppliers

1 buyer

14 suppliers

Description

Invitation to offer for NHS National Generic Pharmaceuticals - Lenalidomide Offer reference number: CM/PHG/21/5638 Period of framework agreement: 01/09/2022 to 31/08/2023 (12 months) with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Lenalidomide: ALL REGIONS: 01/09/2022 to 31/08/2023 (12 months)

Award Detail

1 Mercury Pharmaceuticals (London)
  • Value: £1
2 Accord (Barnstaple)
  • Value: £1
3 Morningside Pharmaeuticals (Loughborough)
  • Value: £1
4 Amarox (Harrow)
  • Value: £1
5 Teva (Castleford)
  • Value: £1
6 Bristol Myers Squibb (Uxbridge)
  • Value: £1
7 Glenmark Pharmaceuticals Europe (Watford)
  • Value: £1
8 Sandoz (Camberley)
  • Value: £1
9 Wockhardt (Wrexham)
  • Value: £1
10 Thornton & Ross (Huddersfield)
  • Value: £1
11 Piramal Critical Care (West Drayton)
  • Value: £1
12 Ranbaxy (Uxbridge)
  • Value: £1
13 Mylan (Hatfield)
  • Value: £1
14 Zentiva Pharma (Guildford)
  • Value: £1

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

Transparency Award Schedule - Sandoz Limited Transparency Award Schedule - Sandoz Limited.pdf Transparency Award Schedule - Bristol Myers Squibb Pharmaceutical Limited Transparency Award Schedule - Bristol Myers Squibb Pharmaceutical Limited.pdf Transparency Award Schedule - Piramal Critical Care Limited Transparency Award Schedule - Piramal Critical Care Limited.pdf Document No. 03 - Framework Agreement and Terms and Conditions - Lenalidomide Document No. 03 - Framework Agreement and Terms and Conditions - Lenalidomide.pdf Parties appointed to the Framework Agreement & SME status - Lenalidomide Parties appointed to the Framework Agreement & SME status - Lenalidomide.xls Transparency Award Schedule - Zentiva Pharma UK Ltd Transparency Award Schedule - Zentiva Pharma UK Ltd.pdf Transparency Award Schedule - Accord-UK Ltd Transparency Award Schedule - Accord-UK Ltd.pdf Transparency Award Schedule - Amarox Limited Transparency Award Schedule - Amarox Limited.pdf Transparency Award Schedule - Glenmark Pharmaceuticals Europe Limited Transparency Award Schedule - Glenmark Pharmaceuticals Europe Limited.pdf Transparency Award Schedule - Mercury Pharmaceuticals Limited Transparency Award Schedule - Mercury Pharmaceuticals Limited.pdf Transparency Award Schedule - Morningside Pharmaceuticals Ltd Transparency Award Schedule - Morningside Pharmaceuticals Ltd.pdf Transparency Award Schedule - Sun Pharma UK Ltd Transparency Award Schedule - Sun Pharma UK Ltd.pdf Transparency Award Schedule - Thornton and Ross Ltd Transparency Award Schedule - Thornton and Ross Ltd.pdf Transparency Award Schedule - Wockhardt UK Limited Transparency Award Schedule - Wockhardt UK Limited.pdf Transparency Award Schedule - Teva UK Ltd Transparency Award Schedule - Teva UK Ltd.pdf Transparency Award Schedule - Viatris UK Healthcare Ltd Transparency Award Schedule - Viatris UK Healthcare Ltd.pdf

Reference

Domains